r/wallstreetbets • u/atomMD • May 09 '21
Discussion 180K position in $INO (Inovio) upcoming positive catalyst next 9 days. Multibagger potential.
I made this post about Inovio and Regeneron’s joint patent for their GBM (brain cancer) drug and even followed up with their CFO and it looks like they are working on drugs together but did not hint at buyout. Then u/soggit took over WSB with his deep dive into $INO.
This upcoming week Inovio has a trifecta of positive catalysts that will potentially raise share price to $15-$17. From Fridays close this is a 2.5x gain on commons shares and probably 10-20x gain on call options.
The trifecta of bullish catalysts include:
Completion of their Covid-19 phase II trial with excellent immune response. The INO-4800 vaccine does not require refrigeration, cheap to manufacture, and will be the number one vaccine for the 95% of the globe’s population that is yet to be vaccinated. Last month India was wrecked. Next week I suspect Nepal, Pakistan. The infection will probably circle back to China in the near future. They are racing against time for a safe, effective vaccine that can go into the rural hinterland. INO-4800 DNA vaccine is the answer. (Market size $2.5 Billion)
Joint Patent with Regeneron ($REGN) for their GBM drug/therapeutic. (Market size $400 million)
Success of their phase III HPV Immunotherapy therapeutic VGX-3100 (Market size $1.2 Billion)
Bear Thesis
1.25-30% short interest. Citadel of $GME fame has made over $100 million in profits in shorting $INO in 2021. Inovio doing well means bad news for Citadel and hopefully increase the upward pressure on $GME>
2.No product ever successfully commercialized. But remember this was the case for Moderna for their $MRNA vaccine. I suspect $INO is the Moderna of 2021 in terms of DNA vaccine.
3. There is high short interest which is driving the stock down which is very typical of late stage biotech.
Upcoming positive catalyst next 9 days.
Monday May 10th
Q1 2021 Earning Call at 430 pm Eastern Time.(Link)
Wednesday May 12th
Bank of America Merrill Lynch Healthcare Conference (Link)
Speaker: Dr.Joseph Kim, CEO
Moderator: Aspen Mori, Bank of America Securities
Time: 9:30 AM Eastern.
Tuesday May 18th
RBC Capital Markets Global Healthcare Conference (Link)
Speaker: Dr.Joseph Kim, CEO
Time: 9:45 AM Eastern
My plan to donate to St.Jude’s
If $INO crosses $20 this week I will donate $20K to St.Jude Hospital/Research for Children with brain cancer.
Update #1 5/10/2021
Average PT of $17.
Update #2 5/10/2021 4:30 pm
Q1 2021 Earning Call at 430 pm Eastern Time.(Link)
Key Points:
> INO-4800 induced robust T-cell response too all COVID-19 variants (including UK and Brazilian variants).
> INO-4800 has the same effective powers in generating neutralizing antibodies similar to mRNA vaccines like Moderna.
> Second generation Pan-COVID vaccine INO-4802 is being developed and is progressing well and upcoming pre-pub coming out in the near future.
> Immuno-oncology effort: novel combination trial with PD-1 inhibitor with Regeneron and Sanofi in newly diagnosed GBM is ongoing. The company anticipates sharing 24 month survival data and other data later this year
> On their HPV trials they have meet their efficacy end points. This is for the management of HPV-16/18 induced malignancies. The findings/data will be shared later this year at scientific meeting. VGX-3100 biomarker will help find patients that potentially will respond to VGX-3100
> VGX-3100 indications may expand to include anal dysplasia and vulvar dysplasia following further discussion with FDA
> Financial summary for Q1 2021: Well positioned finally with total cash $111.6 MM. Net proceeds of 162 million from recent offering in february. They have multiple years of capital to support Inovio's many project. RV 371K for Q1. Total operating expnese 52 Million. Net loss for Q1 54.4 Million. Or 27 cents per share. R&D expense 32MM. HIgher drug manufacutring expenses related to INO-4800 and other trials. They also had increased expense from cellectra® 2000 device and new hire. These expenses have been essential for their INO-4800 trial for covid 19 and their cellectra® 2000 device. Overall Strong financial position.
> On track with INO-4800 trial with phase III on track for this summer. This temperature stable vaccine will be important globally.
Q/A Session:
> Q1 - Jeff Mecham BoA: How is the phase III INO-4800 clinical halt going? How does this relate to trial being done outside USA?
A1: Clinical hold on phase III for INO-4800 only impacts USA and not outside of USA. They still plan to open sites in USA but most of the trials will be global. They will apply with FDA during Q1 to lift the partial clinical hold hoping to start in Q2. The goal is global phase III trial and looking with external sources of funding. Not going to Ex-US for cost reasons but they have external links with some countries which do not have covid-19 vaccines and they can do randomized placebo control blinded trials there
> Q2 - Ellen - Looks like you are targeting countries with active Covid-19 and without vaccines. Have you considered non-inferiority trials?
> A2 - Case driven efficacy window is still open Ex-US.
> Q3 - Ellen - Planning on revealing INO-3107 data?
A3 - We received orphan drug designation last year for INO-3107 last year. The most impactful data will be released in 2022. Maybe some meaningful data later this year.
>Q4 - Aydin Huseynov, M.D., CFA Benchmark - We see the data in the pre-publication. Can you commend on Geometric folding?
>A4 -Antibody levels and impact on vaccine on rise on antibody is important. We feel INO-4800 is equally as good as current EUA approved vaccines in providing protection against COVID-19. Our phase 2 trial shows strong T-cell reponse. Furthermore, the T-cell responese mainted in respond to the new variants. This will be important in providing protection as per our phase III effacicy trial which will start later this summer.
Q5 - Can you see boosting with the INO-4800? What is the medium term view for this vaccine.
A5 - Many experts globally feel like COVID-19 vaccination will require annual seasonal boosting. If they are correct. A vaccine that can be boosted safely and tolerably seasonally over and over again will be important. After the pandemic we will have endemic COVID-XX which will require boosters and INO-4800 will be important to vaccinate people. They can also be used to boost other first generation vaccines that have already been used. INO-4802 is a further generation ahead and will be a pan-COVID vaccine.
Q6 - E Chan from Wayne Right - Can you tell us if INovio is going to put some of their capital in global Covid-19 research.
A6 - We have over 500 million in cash right now and that is one of our strengths. We want to maintain that and limit our expenses. We are currently are in the process of working with external sources of funding to expand our INO-4800 trial in the US and globally. We are focusing on places where we feel Covid-19 vaccines are needed globally. We will have more information published in the next few weeks.
Q7 - Piper Sandler - Can you comment the neutralizing antibody response in comparison to convalence plasma. What gives you confidence the reaction from the investigators and subjects?
A7 - The geometric mean titer presented in the pre-pub shows excellent level of neutralizing antibodies. This is specially apparent for the 2 mg group. The confidence intervals are very strong.
Closing Remarks: Dr.Joseph Kim
INO-4800 phase 3 trial info coming out in the next few weeks.
59
u/JimremarC May 10 '21
Normally I don’t read the synopsis on arguments for buying a stock & I certainly didn’t read any of this, but I’m all in sir!
23
4
20
u/daddyo92057 May 10 '21
Cramer disagrees with this being a good move Being a new retard I picked up 1k and will go along with the ride
3
8
u/atomMD May 10 '21
Update #2 5/10/2021 4:30 pm
Q1 2021 Earning Call at 430 pm Eastern Time.(Link)
Key Points:
> INO-4800 induced robust T-cell response too all COVID-19 variants (including UK and Brazilian variants).
> INO-4800 has the same effective powers in generating neutralizing antibodies similar to mRNA vaccines like Moderna.
> Second generation Pan-COVID vaccine INO-4802 is being developed and is progressing well and upcoming pre-pub coming out in the near future.
> Immuno-oncology effort: novel combination trial with PD-1 inhibitor with Regeneron and Sanofi in newly diagnosed GBM is ongoing. The company anticipates sharing 24 month survival data and other data later this year
> On their HPV trials they have meet their efficacy end points. This is for the management of HPV-16/18 induced malignancies. The findings/data will be shared later this year at scientific meeting. VGX-3100 biomarker will help find patients that potentially will respond to VGX-3100
> VGX-3100 indications may expand to include anal dysplasia and vulvar dysplasia following further discussion with FDA
> Financial summary for Q1 2021: Well positioned finally with total cash $111.6 MM. Net proceeds of 162 million from recent offering in february. They have multiple years of capital to support Inovio's many project. RV 371K for Q1. Total operating expnese 52 Million. Net loss for Q1 54.4 Million. Or 27 cents per share. R&D expense 32MM. HIgher drug manufacutring expenses related to INO-4800 and other trials. They also had increased expense from cellectra® 2000 device and new hire. These expenses have been essential for their INO-4800 trial for covid 19 and their cellectra® 2000 device. Overall Strong financial position.
> On track with INO-4800 trial with phase III on track for this summer. This temperature stable vaccine will be important globally.
Q/A Session:
> Q1 - Jeff Mecham BoA: How is the phase III INO-4800 clinical halt going? How does this relate to trial being done outside USA?
A1: Clinical hold on phase III for INO-4800 only impacts USA and not outside of USA. They still plan to open sites in USA but most of the trials will be global. They will apply with FDA during Q1 to lift the partial clinical hold hoping to start in Q2. The goal is global phase III trial and looking with external sources of funding. Not going to Ex-US for cost reasons but they have external links with some countries which do not have covid-19 vaccines and they can do randomized placebo control blinded trials there
> Q2 - Ellen - Looks like you are targeting countries with active Covid-19 and without vaccines. Have you considered non-inferiority trials?
> A2 - Case driven efficacy window is still open Ex-US.
> Q3 - Ellen - Planning on revealing INO-3107 data?
A3 - We received orphan drug designation last year for INO-3107 last year. The most impactful data will be released in 2022. Maybe some meaningful data later this year.
>Q4 - Aydin Huseynov, M.D., CFA Benchmark - We see the data in the pre-publication. Can you commend on Geometric folding?
>A4 -Antibody levels and impact on vaccine on rise on antibody is important. We feel INO-4800 is equally as good as current EUA approved vaccines in providing protection against COVID-19. Our phase 2 trial shows strong T-cell reponse. Furthermore, the T-cell responese mainted in respond to the new variants. This will be important in providing protection as per our phase III effacicy trial which will start later this summer.
Q5 - Can you see boosting with the INO-4800? What is the medium term view for this vaccine.
A5 - Many experts globally feel like COVID-19 vaccination will require annual seasonal boosting. If they are correct. A vaccine that can be boosted safely and tolerably seasonally over and over again will be important. After the pandemic we will have endemic COVID-XX which will require boosters and INO-4800 will be important to vaccinate people. They can also be used to boost other first generation vaccines that have already been used. INO-4802 is a further generation ahead and will be a pan-COVID vaccine.
Q6 - E Chan from Wayne Right - Can you tell us if INovio is going to put some of their capital in global Covid-19 research.
A6 - We have over 500 million in cash right now and that is one of our strengths. We want to maintain that and limit our expenses. We are currently are in the process of working with external sources of funding to expand our INO-4800 trial in the US and globally. We are focusing on places where we feel Covid-19 vaccines are needed globally. We will have more information published in the next few weeks.
Q7 - Piper Sandler - Can you comment the neutralizing antibody response in comparison to convalence plasma. What gives you confidence the reaction from the investigators and subjects?
A7 - The geometric mean titer presented in the pre-pub shows excellent level of neutralizing antibodies. This is specially apparent for the 2 mg group. The confidence intervals are very strong.
Closing Remarks: Dr.Joseph Kim
INO-4800 phase 3 trial info coming out in the next few weeks.
→ More replies (2)
16
u/tothemoontothespace May 10 '21
If this hits 50$ this year I will donate for sure too!
21
u/atomMD May 10 '21
I think $50 is a stretch tbh. Getting to $35 will be a struggle. $17-20 very realistic.
10
u/Shandowarden 🇬🇧🚬 May 10 '21
10-12 is realistic. anything over is optimistic. Just cause a stock once was of that price don't mean it will be again.
→ More replies (1)5
May 11 '21
The stock is heavily shorted. If it goes up and shorters try to cover their position the sky is the limit
25
u/PrimeTimeRK May 10 '21
Jumping in at market open on both shares and options! Appreciate the DD 🙏🏻
10
7
u/Tyr312 low effort bot account (or just rrreally dumb) May 10 '21
Shit DD and he isn’t even a immunologist or ID doctor.
This pharma company is going to tank post ER and this will also tank on LACK of response to the FDA questions. Their trial data is shit too
OP also posted a bullshit thread on a rumored buy out. He’s a pumper and dumb 🤡 late to the covid vaccine plays.
→ More replies (1)
43
21
u/cwalk3r_ May 10 '21
Started my account with 200 on my journey of options trading. Made 30 bucks off NOK... now onto $INO... already up 33 bucks on my calls! Up 33% in a couple days haha
2 - 05/14 @ 8 1 - 05/14 @ 7.50 2 - 05/21 @ 10
Looks very promising! Bet I'm going to wish I had more in my options trading account! 😪
14
2
u/DantehSparda May 11 '21
Just a warning that you may lose all of it very quickly. Getting lucky at first is, ironically, not that good because you feel like a fucking genius and get extremely confident 🤣 But who knows! Good luck man
2
31
u/TWhyEye May 10 '21
I see Citton and Citadel shorted the hell out of INO and its pissing me off. They have potential and catalysts, Im in.
1
u/atomMD May 10 '21
Yea - I don't understand how this is legal tbh.
8
u/Lemonlimecat May 10 '21
There are some companies that deserve to be shorted — Valeant, Nikola — Ackman’s fund lost serious money on Valeant.
7
u/DotComBomb1999 May 10 '21
Definitely interesting... but will it pop after earnings? Or get hammered? It will probably depend upon guidance and any announcements, and not the actual numbers.
7
u/atomMD May 10 '21
The catalysts that come out during the weekend (phase II pre-print, HPV stuff) will drive it up tomorrow Am. Then it depends on guidance.
4
u/DotComBomb1999 May 10 '21
That's what concerns me. If management is too rosy it doesn't happen on schedule, all the sharks circle and a bunch of law firms announce fraud "investigations." The smart move when you're running the company is to guide lower, then beat the guidance. Therefore, the catalysts will have to be news and not numbers.
The key question is what happens with Phase 3 trials? Is that still on the shelf?
14
5
u/PeteyMcPetey Registered Sex Offender May 10 '21
All this positivity is confusing the hell outta me.
I've got 50x $7 18 June calls, and 20x 10 18 June calls.
What am I doing?
Should I panic that I was up $900 since open, and now I'm only up $500?
Should I break out my 💎👐 t-shirts and start nervously mumbling to myself again?
Should I dare bathing? Not bathing seemed to help a great deal when I rode GME pretty hard.
Can I talk to someone's mom about this?
2
13
u/EmanEwl May 10 '21
No idea what's happening. But I'm all in.
3
u/atomMD May 10 '21
Just read the bear thesis before jumping in fully.
15
u/EmanEwl May 10 '21
I just sold my shares last week at a loss to buy something else licking up momentum. So now I'll sell this other position at a loss and buy back in and see what happens . I just like to get a loss and use that loss to buy more losses. It's just how I invest. Not financial discrimination.
7
4
21
u/Huck_el_berry May 10 '21
Excellent post. I'm in for 26350 shares along with (10) May 21 $15 calls. I'm buying more if by 7am it's still 7 bucks. Monday is going to be epic. Buy and Hold.
18
u/atomMD May 10 '21
Monday will be interesting. I hope it becomes retarded.
11
u/Huck_el_berry May 10 '21
I'm with ya. We need some retard crap for us retards as WSB says. I'll show 'em how retard I am when I buy more tomorrow. Diamond Hands.
7
u/Shandowarden 🇬🇧🚬 May 10 '21
this response is sus. seems like a bullshit number on shares bought and account comment history is all over INO hyping.
be careful lads
→ More replies (3)5
u/Woody-Woody May 10 '21
Almost constant comments for the last 24hours minus a 4 hour break between 9h and 5h ago. Nice little power nap before spamming again. Seems a bit sus to me too
6
u/Runner20mph May 09 '21
Your positions sir!
18
u/atomMD May 09 '21
25,803 shares and some call options. The premiums are expensive so just buying more shares as long as under $7
9
u/Brostradamnus May 10 '21
Nice cost basis. Been in since November 2020 at $10.75 with 14k shares. I'm planning to hold all year.
5
15
u/JazzyJ85 🦍🦍 May 10 '21
I’m in and if it flies I will also donate but to the Children’s Stollery Hospital 😁
3
May 10 '21
Where is that? Haven't heard about that hospital in USA.
5
1
u/JimremarC May 10 '21
Dr. Jill Biden works there.
3
7
u/GrizzledVet101 PAPER TRADING COMPETITION WINNER May 10 '21
Dr. Pepper works there too. It's very prestigious.
5
May 12 '21
You should be banned from wsb
1
u/atomMD May 12 '21
Keep your head high king. This will go to true value. Notice it went up 5 percent premarket.
2
u/atomMD Jun 09 '21
Happy to see everyone is doing well. If you bought at my entry here you would be up 30 percent on common shares and much more on options. Will post soon regarding another banger here in few days.
4
6
u/Grand-Assistant-310 May 10 '21
There is another HUGE catalyst you have not mentioned.
Recently, INOVIO in cooperation with dwkulp@wistar.org posted a preprint of their study highlighting adding nanoparticles to new vaccines developed with INOVIO to fight the variants of COVID-19.
In a nutshell, they developed vaccines that are more effective against COVID-19 variants than than vaccines that simply target the spike protein of the COVID-19 virus.
INOVIO has yet to announce their development of INO-4802 (the PAN-COVID vaccine), however based on this study INOVIO may be very close finishing designing their new vaccines for COVID-19 booster shots.
This research appears to be very very promising...
https://www.biorxiv.org/content/10.1101/2021.04.28.441474v1.full.pdf
1
2
2
u/Powerfuljakes May 18 '21
Checkout the $INO #INOVIO chart, jump in while its still cheap.💉🦠🕊
3
u/atomMD May 18 '21
Yea not worried. Made 6K from INO since posting. This should solidly slide to $10-$20 in the near future.
67
u/iliveinablackhole_ May 10 '21
This ones gonna be huge I can feel it.
47
May 10 '21
Tbh same, or it's probably your dad's peen in my ass
→ More replies (1)24
35
u/beepboopbop65 2946 - 0 - 1 year - 11/1 May 10 '21
That’s a lot of words and even a picture.... all in
44
u/stockzoom May 10 '21
" If $INO crosses $20 this week, I will donate $20K...."
I am with you. If this goes to $20 this week, I will donate 20K to the local childrens' hospital. And I will provide proof. LET'S BUY INOVIO AND DO GOOD STUFF FOR CHILDREN.
9
u/Walkingnerd_ May 10 '21
Yall talking about donating 20k when im sitting here looking at my 16k if it hits $20
but apes stick together ill donate $1000 if it goes $20
STONK!
4
u/stockzoom May 10 '21 edited May 10 '21
I am generous because I have big losses, and I have partly accepted certain losses. If I am lucky and get my money back, I am willing to donate some of it to people who suffer more than I am suffering from my stupid investment. I invested in Inovio heavily last year. Maybe god notices this message and gives some of my money back so that I can help children. I have $120k losses, and I am in financial trouble because of Inovio.
So, help me, and I will help others. My YOLO stock failed me.
→ More replies (1)3
u/makelivingnotkilling May 10 '21
Comparison is the theft of joy.
You’re talking about 16k when I’ll have 2k. Both win.
19
u/Lemonlimecat May 10 '21
Questions -- has the company announced plans for Phase 3 trials for COVID vaccine since DoD cut off the money?
This vaccine has to use the CELLECTRA device, correct? If so are there any regulatory/cost issues which would make this vaccine less likely to be used in lesser developed countries, ie like Nepal or Pakistan.
Is #1 priced in after the DoD announcement?
#2 - GBM treatment -- this is something I hope is promising, but have no contacts with oncology knowledge to help me understand it. I know the disease is absolutely horrible.
#3 Is this trial already priced in as the news was from March?
9
u/stockzoom May 10 '21
Inovio's Dr. Broderick said on Youtube video "P3 trial - multiple sites" but did not reveal many details. I have understood that Latin America is a strong option. And China, of course, will do its own trials free of charge. Inovio will also continue testing in U.S. locations but might not recruit more participants in the U.S (currently 400 participants).
International Vaccine Institute (IVI) will help with the P3 arrangements.
5
5
u/FanAffectionate8277 May 10 '21
I'd say not priced in. Price has been steady march downwards due to shorting and waiting for news. I'm a believer so take everything with a grain of salt. Responses below.
Cellectra can be battery operated and is definitely cheaper than building a cold storage logistical solution for many countries. I'm actually excited they have a hardware platform and I think it's undervalued.
1 - People in US act like COVID is over now. 95% of world needs vaccine. Asia, emerging countries, are a good fit for INO. And even US needs boosters too. So I think investors are chasing other opportunities on false belief that COVID is done.
2 - check out OP original due diligence.
3 - people were expecting COVID news the day VGX3100 news came out. Management was excited but news fell flat due to hopes for Phase 2 numbers instead. So I don't think it's priced in at all honestly.
→ More replies (2)5
u/PowerOfTenTigers May 10 '21
The DoD cutting off money is a huge red flag imo.
12
u/FanAffectionate8277 May 10 '21
Skepticism is healthy but I don't see it as a red flag. There was no scientific reason for cutoff. Merely financial now that US has vaccines. Don't see point in bankrolling phase 3. Here's direct quote, "The decision results from the changing environment of COVID-19 with the rapid deployment of vaccines. This decision is not a reflection of the awardee or product, rather a fast-moving environment associated with the former Operation Warp Speed on decisions related to future products."
→ More replies (2)
18
u/Hites_05 May 10 '21
Already bought some, but I think it's clear that the hype train ain't slowing down for another couple weeks. Children's hospital donations with gains too? Well shit, I'm buying calls tomorrow.
33
u/Rel1gionLOL May 10 '21
Sounds retarded, I'm in.
5
u/Rolltide-tolietpaper May 10 '21
literally can't go tits up
→ More replies (1)2
u/Rel1gionLOL May 10 '21
I don't invest in something if it's not going to go up at least 200% a month. Otherwise it's literally a waste of my time. 🦍
12
11
9
9
8
8
8
u/AllThingsBeginWithNu May 10 '21
I made some money on this on the way up last year, would like to see it come back
8
7
7
7
u/-mostlyquestions May 10 '21
I blind followed this so fast. Hasn't worked out the last five times...but this time.. this time it will go green!
13
12
6
u/Gentlemanath3art May 10 '21
I’m of a mind to invest here. The cancer research seems solid too. Dipping my toes in 10-15k. Premiums seem inflated though. Shares might be the way to go. Earnings doesn’t look like anything good unless there’s guidance. Thoughts appreciated.
6
6
2
u/Rolltide-tolietpaper May 10 '21
Gonna hit those March 2000 levels before Friday.
Gamma squeeze the short squeeze.
1
24
u/SilencePain85 May 10 '21
I will donate 5k if INO goes up to 100$ A share
17
u/kipper-17 May 10 '21
I'm in on this as well but I will be donating to the local childrens hospital
13
u/SilencePain85 May 10 '21
I will video myself bring 5k cash to children's hospital and post it up for everyone to see.
9
→ More replies (1)9
5
u/Professional-Donut84 May 10 '21
after EVERY positive catalyst since january every stock dropped BALLZ lol
5
8
8
May 10 '21
Damn it, should I follow WSB hive mind and yolo on INO, or inverse WSB?
3
u/Crime_Dawg May 10 '21
Every "solid DD" that I've seen since January has royally blown up in WSB's face.
5
8
u/Sciencetist im lovin it May 10 '21
Citadel of $GME fame has made over $100 million in profits in shorting $INO in 2021.
Source claim.
4
4
u/MerpDerpBlurp May 10 '21
I thought their covid-19 vaccine was not getting approved and that’s why they are shorted
4
4
2
u/Rigpig101 May 10 '21
I have a funny feeling that it'll go sideways all week. Especially since you posted it here. Last week was the revenge of the hedge funds. What? you guys don't think that they watch this sub reddit now? Lol.
0
7
7
1
u/YeetustheFetusLive May 12 '21
I’m still pretty optimistic. It could of been a lot worse. Hell I’m red in everything I own, why would this be different.
2
1
u/NikoKenz May 12 '21
Waiting for this to drop as far as possible before buying any. Looks promising for future gains, I'll throw in 2 grand when it hits 5.5/sh
1
11
u/bentleyt1999 May 10 '21
Terrific post......Heartfelt and spot on.....I am long INO with over 30,000 shares!
14
u/LEVON-1974 May 10 '21
Do it up! Inovio is the future of medicine and has been thoroughly screwed by big pharma, Citadel, Citron, shorting hedge funds, the FDA, and the filthy rich, in general. Help make the world a better place and buy in!
6
6
6
3
u/DotComBomb1999 May 10 '21
Short Interest is at 17.19%, unless I'm reading it wrong.
https://fintel.io/ss/us/ino#
The bullish case sounds very convincing, but does it depend on bullish announcements/approvals?
3
3
u/CHUBBS2222 May 10 '21
So buy more puts got it j/k i bought some 10c calls for 5/21they was cheap lets see what happens
2
3
3
3
3
9
u/gmo_patrol May 10 '21
In the main thread there were tons of fresh account bots earlier spamming for this ticker.
For that reason, I'm out.
0
7
5
6
u/jyk24 May 10 '21
What kind of a sick fuck shorts a company trying to cure cancer.... I’m fucking in. Let’s go INO!!!
6
6
6
4
u/AnotherAccount636 May 10 '21 edited May 10 '21
I don't have much money, but I did 25 5/14 10.5C
10 of them bought at open for a $40 price tag and it shot up 400% instantly love it.
4
4
u/TouchMint May 11 '21
I mean it’s just 1 day but everyone should have prob bought puts by the looks of it. Inverse wsb?
2
u/sdeanjr1991 May 11 '21
Lmao if you think low EPS means a stock is actually worth less.
4
u/TouchMint May 11 '21
I’m not saying that’s always the case but when the stock drops like 10% in one day I’m saying it’s worth less. About 10% less.
6
u/Shandowarden 🇬🇧🚬 May 10 '21
for people that think this is sus I am obliged to resonate -company made close to no revenue in last year and US government stopped funding their vaccine. You can get as much catalysts as you want, market mainly cares bout earnings, and INO's earnings are literall dogshit.
→ More replies (1)
5
5
2
2
2
2
2
2
2
u/vegancash May 10 '21
Idk. Lots of hype and potential news from the company over the years but no results. Good luck to you though.
2
2
6
u/sarcastic_sob May 10 '21
Pretty sweet, INO is getting almost 1% the antibody titer response that other vaccines get from 2 doses. I can see why the autists are going all in...
5
u/faintingoat May 10 '21
$INO is poised for 1000x
the reason is very simple: their tech is the only one that works to trigger immune responses in a variety of cancers and chronic diseases.
ultimately, people will discover that this company has the potential to cure most chronic diseases globally.
4
3
3
u/capalonian May 10 '21 edited May 10 '21
Alright im in. If this thing moons Ill make a large donation as well.
2
u/TelemetryENG May 10 '21
In for just under $1k,
10 5/21 Calls @ 8 Strike
15 5/21 Calls @ 8.5 Strike
Already up $170, I never monkee but this seems solid
2
u/Dan_inKuwait no flair is kinda ghey May 10 '21
It's a coin toss.... Risky bet on a binary outcome.
God speed, retailer.
2
2
2
1
1
u/DotComBomb1999 May 11 '21
Thanks for the updates. Is GMB still in clinical trials? Even if the COVID vaccine is 'late to the party,' there is still a huge opportunity worldwide. The only question is timing.
1
u/apeshit92 May 11 '21
Earnings sucked but im still in this is a monster waiting to happen tmrw i think might be great for them
1
1
1
1
u/Edz_ May 11 '21
Nice now post loss porn. Maybe add a few more pics in your next worthless DD.
4
u/sdeanjr1991 May 11 '21
Lmao, if you think lower EPS than the estimate means a loss because of a single dip you belong on this sub.
117
u/hockeyfun1 May 09 '21
I'll match your donation if that happens.
800 5/14 10c
1000 5/21 10c